Chinese Journal of Cancer Research

, Volume 22, Issue 3, pp 218–223

Detection of human papilloma virus type 16 E6 mRNA in laryngeal squamous cell carcinoma by in situ hybridization

  • Jiang Hai-rong
  • Wang Peng
  • Li Yong
  • Ning Tao
  • Rao Xiao-song
  • Liu Bao-guo
Original Article

Abstract

Objective

Laryngeal squamous cell carcinoma (LSCC) is a common malignant tumor in Northeast China and is frequently associated with well-established risk factors like smoking and alcohol abuse. Human papilloma virus (HPV) is an epitheliotropic oncogenic virus that has been detected in a variety of head and neck tumors including LSCC. This retrospective study was to investigate the prevalence of HPV infection in patients with LSCC.

Methods

In situ hybridization was performed in 99 patients with LSCC to detect the expression of HPV-16 E6 mRNA.

Results

The positive rate of HPV16 E6 mRNA was 36.36% (36/99) in laryngeal squamous cell carcinoma (LSCC), whereas only 3 of 50 (6%) specimens of the normal laryngeal mucosa as a control group showed positive results (P<0.05).Additionally, there was no corelation between HPV16 and age, gender, clinical stage, nodal status and tumor site (P>0.05).

Conclusion

The results suggest that the increased prevalence of HPV infection compared to normal laryngeal mucosa and the fact that high-risk HPV types (especially type 16) were the most frequently identified do not allow the exclusion of HPV as a risk factor in laryngeal squamous cell carcinoma. However, their clinical value remains to be further investigated.

Key words

Laryngeal squamous cell carcinoma Human papilloma virus In situ hybridization 

CLC number

R739.63 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses[J]. Virology 2004; 324:17–27.CrossRefPubMedGoogle Scholar
  2. [2]
    Fliss DM, Noble-Topham SE, McLachlin M, et al. Laryngeal verrucous carcinoma: a clinicopathologic study and detection of human papillomavirus using polymerase chain reaction[J]. Laryngoscope 1994; 104:146–152.PubMedGoogle Scholar
  3. [3]
    Karlsen F, Kristensen G, Holm R, et al. High incidence of human papillomavirus in 146 cervical carcinomas. A study using three different pairs of consensus primers, also detecting viral genomes with putative deletions[J]. Eur J Cancer 1995; 31A:1511–1516.CrossRefPubMedGoogle Scholar
  4. [4]
    Mounts P, Shah KV, Kashima H. Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx[J]. Proc Natl Acad Sci USA 1982; 79: 5425–5429.CrossRefPubMedGoogle Scholar
  5. [5]
    Hennessey PT, Westra WH, Califano JA. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications[J]. J Dent Res 2009; 88:300–306.CrossRefPubMedGoogle Scholar
  6. [6]
    Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type[J]. Hematol Oncol Clin North Am 2008; 22:1125–1142.CrossRefPubMedGoogle Scholar
  7. [7]
    Gorgoulis V, Rassidakis G, Karameris A, et al. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings[J]. Virchows Arch 1994; 425:481–489.CrossRefPubMedGoogle Scholar
  8. [8]
    Arndt O, Brock J, Kundt G, et al. Detection of human papillomavirus DNA in formalin fixed invasive squamous cell carcinoma of the larynx with polymerase chain reaction (PCR)[J]. Laryngorhinootologie 1994; 73: 527–532.CrossRefPubMedGoogle Scholar
  9. [9]
    Brandwein MS, Nuovo GJ, Biller H. Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers[J]. Ann Otol Rhino1 Laryngol 1993; 102:309–313.Google Scholar
  10. [10]
    Hoshikawa T, Nakajima T, Uhara H, et al. Detection of human papillomavirus DNA in laryngeal squamous cell carcinomas by polymerase chain reaction[J]. Laryngoscope 1990; 100: 647–650.CrossRefPubMedGoogle Scholar
  11. [11]
    Ishibashi T, Matsushima S, Tsunokawa Y, et al. Human papillomavirus DNA in squamous cell carcinoma of the upper aerodigestive tract[J]. Arch Otolaryngol Head Neck Surg 1990; 116:294–298.PubMedGoogle Scholar
  12. [12]
    Pérez-Ayala M. Ruiz-Cabello F, Esteban F, et al. Presence of HPV 16 sequences in laryngeal carcinomas[J]. Int J Cancer 1990; 46:8–11.CrossRefPubMedGoogle Scholar
  13. [13]
    Mies C, Houldsworth J, Chaganti RS. Extraction of DNA from paraffin blocks for Southern blot analysis[J]. Am J Surg Pathol 1991; 15:169–174.CrossRefPubMedGoogle Scholar
  14. [14]
    Mirzamani N, Salehian P, Farhadi M, et al. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization[J]. Exp Mol Pathol 2006; 81:231–234.CrossRefPubMedGoogle Scholar
  15. [15]
    Li T, Lu ZM, Chen KN, et al. Human papillomavirus type 16 is an important infectious factors in the high incidence of esophageal cancer in Anyang area of China[J]. Carcinogensis 2001; 22:929–934.CrossRefGoogle Scholar
  16. [16]
    Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia[J]. Microbiol Mol Biol Rev 2004; 68: 362–372.CrossRefPubMedGoogle Scholar
  17. [17]
    Parkin DM. The global health burden of infection-associated cancers in the year 2002[J]. Int J Cancer 2006; 118:3030–3044.CrossRefPubMedGoogle Scholar
  18. [18]
    Klein F, Amin Kotb WF, Petersen I. Incidence of human papilloma virus in lung cancer[J]. Lung Cancer 2009; 65:13–18.CrossRefPubMedGoogle Scholar
  19. [19]
    Rezazadeh A, Laber DA, Ghim SJ, et al. The role of human papilloma virus in lung cancer: a review of the evidence[J]. Am J Med Sci 2009; 338:64–7.CrossRefPubMedGoogle Scholar
  20. [20]
    D’souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer[J]. N Engl J Med 2007; 356:1944–56.CrossRefPubMedGoogle Scholar
  21. [21]
    Scheffner M, Nuber U, Huibregtse JM. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade[J]. Nature 1995; 373: 81–3.CrossRefPubMedGoogle Scholar
  22. [22]
    Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins[J]. Science 1992; 258:424–429.CrossRefPubMedGoogle Scholar
  23. [23]
    Maciag PC, Villa LL. Genetic susceptibility to HPV infection and cervical cancer[J]. Braz J Med Biol Res 1999; 32:915–922.CrossRefPubMedGoogle Scholar
  24. [24]
    Pillai MR, Halabi S, McKalip A, et al. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer[J]. Cancer Epidemiol Biomarkers Prev 1996; 5:329–335.PubMedGoogle Scholar
  25. [25]
    Pou MA, Rimmell FL, Jordan JA, et al. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis[J]. Ann Otol Rhinol Laryngol 1995; 104: 758–762.PubMedGoogle Scholar
  26. [26]
    Poljak M, Gale N, Kambic V. Human papillomaviruses: a study of their prevalence in the epithelial hyperplastic lesions of the larynx[J]. Acta Otolaryngol Suppl 1997; 527:66–9.CrossRefPubMedGoogle Scholar
  27. [27]
    Clayman GL, Stewart MG, Weber RS, et al. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival[J]. Arch Otolaryngol Head Neck Surg 1994; 120:743–748.PubMedGoogle Scholar
  28. [28]
    Baoguo L, Zheming L, Yong L, et al. Detection of human papillomavirus IL1 −16 and −18 DNA and epstein-barr virus DNA in laryngean carcinoma[J]. Chin J Cancer Res 2005; 17:121–126.CrossRefGoogle Scholar
  29. [29]
    Ringström E, Peters E, Hasegawa M, et al. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck[J]. Clin Cancer Res 2002; 8:3187–3192.PubMedGoogle Scholar
  30. [30]
    Badaracco G, Venuti A, Morello R, et al. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters[J]. Anticancer Res 2000; 20 (2B):1301–1305.Google Scholar
  31. [31]
    Syrjänen K, Syrjänen S, Lamberg M, et al. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis[J]. Int J Oral Surg 1983; 12:418–424.CrossRefPubMedGoogle Scholar
  32. [32]
    Gillison ML, Koch WM, Capone RB. Evidence for a casual association between human papillomavirus and a subset of head and neck cancers[J]. J Natl Cancer Inst 2000; 92:709–720.CrossRefPubMedGoogle Scholar
  33. [33]
    D’souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer[J]. N Engl J Med 2007; 356:1944–1956.CrossRefPubMedGoogle Scholar
  34. [34]
    Herrero R, Castellsagué X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on cancer multicenter study[J]. J Natl Cancer Inst 2003; 95:1772–1783.PubMedGoogle Scholar
  35. [35]
    Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review[J]. Cancer Epidemiol Biomarkers Prev 2005; 14: 467–475.CrossRefPubMedGoogle Scholar
  36. [36]
    Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer[J]. Int J Cancer 2006; 119:2620–2623.CrossRefPubMedGoogle Scholar
  37. [37]
    Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas[J]. Cancer 2001; 92:2875–2884.CrossRefPubMedGoogle Scholar
  38. [38]
    Venuti A, Badaracco G, Rizzo C, et al. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization[J]. J Exp Clin Cancer Res 2004; 23:561–566.PubMedGoogle Scholar
  39. [39]
    Paz IB, Cook N, Odom-Maryon T, et al. Human papillomavirus (HPV) in head and neck cancer. An association of HPV with squamous cell carcinoma of Waldeyer’s tonsillar ring[J]. Cancer 1997; 79: 595–604.CrossRefPubMedGoogle Scholar

Copyright information

© Chinese Anti-Cancer Association and Springer Berlin Heidelberg 2010

Authors and Affiliations

  • Jiang Hai-rong
    • 1
  • Wang Peng
    • 2
  • Li Yong
    • 3
  • Ning Tao
    • 3
  • Rao Xiao-song
    • 4
  • Liu Bao-guo
    • 2
  1. 1.Department of Clinical LaboratoryChongqing Medical UniversityChongqingChina
  2. 2.Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Head and Neck SurgeryPeking University School of Oncology, Beijing Cancer Hospital & InstituteBeijingChina
  3. 3.Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GeneticsPeking University School of Oncology, Beijing Cancer Hospital & InstituteBeijingChina
  4. 4.Department of PathologyPeking University Shougang HospitalBeijingChina

Personalised recommendations